Top Stories
The companies will combine clinical trial findings with real-world patient data to investigate treatment outcomes, including measures of health beyond weight loss.
The MIT spinout says six of the world's 20 largest drugmakers have partnered with it to access its biomolecular AI models.
The decision follows scrutiny over her positions on vaccines, mifepristone and other health policy issues.
The Mass General Brigham spinout is building AI models that can draw insights from patients' medical histories.
The company plans to use the mild subgroup findings to support its FDA application for Spectris.
Conference News
SACRAMENTO, Calif., Nov. 16, 2026 — Sutter Health researchers have launched a biobank registry to accelerate research into LATE, a lesser-known form of dementia that can mimic Alzheimer’s disease but...
LAS VEGAS, NV, UNITED STATES, November 18, 2026 /EINPresswire.com/ -- AstroDoc, Inc., developer of the ASTRID AI Health Intelligence platform, today announced a major upgrade introducing optional pers...
Exhibiting at RSNA Booth #1759 (South Hall Level 3), featuring live demonstrations of TIME Best Inventions of 2026 honoree Nanox.ARC X and Nanox.AI solutions, part of Nanox’s integrated, end-to-end me...
BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- A new, free, 5-minute cognitive test went live online today in connection with a presentation of a further analysis of the data from the 2800-person Advanced ...
Direct brainwave measurement, phone-free sleep monitoring and personalized sleep guidance, introduced at HLTH USA 2026LAS VEGAS, NV, UNITED STATES, November 18, 2026 /EINPresswire.com/ -- slowave Inc....



